ATE143960T1 - Substituierte arylamine und heteroarylamine, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzung - Google Patents

Substituierte arylamine und heteroarylamine, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzung

Info

Publication number
ATE143960T1
ATE143960T1 AT90401850T AT90401850T ATE143960T1 AT E143960 T1 ATE143960 T1 AT E143960T1 AT 90401850 T AT90401850 T AT 90401850T AT 90401850 T AT90401850 T AT 90401850T AT E143960 T1 ATE143960 T1 AT E143960T1
Authority
AT
Austria
Prior art keywords
heteroarylamines
composition containing
pharmaceutical composition
optionally substituted
production
Prior art date
Application number
AT90401850T
Other languages
English (en)
Inventor
Jean-Marc Kamenka
Alain Privat
Robert Rubin Chicheportiche
Jean Costentin
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of ATE143960T1 publication Critical patent/ATE143960T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/08Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
AT90401850T 1989-06-29 1990-06-27 Substituierte arylamine und heteroarylamine, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzung ATE143960T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8908704A FR2649105B1 (fr) 1989-06-29 1989-06-29 Arylamines et heteroarylamines substituees, leur procede de preparation et composition pharmaceutique les contenant

Publications (1)

Publication Number Publication Date
ATE143960T1 true ATE143960T1 (de) 1996-10-15

Family

ID=9383267

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90401850T ATE143960T1 (de) 1989-06-29 1990-06-27 Substituierte arylamine und heteroarylamine, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzung

Country Status (7)

Country Link
EP (1) EP0406111B1 (de)
JP (1) JP3047112B2 (de)
AT (1) ATE143960T1 (de)
CA (1) CA2019622C (de)
DE (1) DE69028808T2 (de)
ES (1) ES2095242T3 (de)
FR (1) FR2649105B1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763951B1 (fr) * 1997-06-03 2000-12-01 Sod Conseils Rech Applic Nouveaux derives de phencyclidines, des procedes pour leur preparation et des compositions pharmaceutiques les contenant
HUP0002302A3 (en) 1997-06-03 2001-12-28 Sod Conseils Rech Applic Phencyclidine derivatives, preparation methods and pharmaceutical compositions containing same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0317953A3 (de) * 1987-11-24 1990-12-05 G.D. Searle & Co. N-(1-Thienylcycloalkyl)alkenylamine zur Behandlung von neurotoxischen Krankheiten

Also Published As

Publication number Publication date
FR2649105B1 (fr) 1994-04-29
EP0406111B1 (de) 1996-10-09
ES2095242T3 (es) 1997-02-16
EP0406111A1 (de) 1991-01-02
DE69028808T2 (de) 1997-04-30
JP3047112B2 (ja) 2000-05-29
DE69028808D1 (de) 1996-11-14
CA2019622C (en) 2002-01-08
JPH0344356A (ja) 1991-02-26
FR2649105A1 (fr) 1991-01-04
CA2019622A1 (en) 1990-12-29

Similar Documents

Publication Publication Date Title
KR960701019A (ko) 신규의 4-아미노피리딘, 이것의 제조방법 및 이것을 함유하는 약제(new 4-aminopyridines, process for preparing the same and me-dicaments containing the same)
ATE158568T1 (de) Verfahren zur herstellung von quaternären diestern
DE68914488D1 (de) 2-(2-Hydroxy-3-phenoxypropylamino)ethylphenoxyacetamide, Verfahren und Zwischenprodukte zu deren Herstellung.
ATE143943T1 (de) Arylglycinamidderivate, verfahren zur deren herstellung und deren verwendung zur therapie der dysurie
DK511383A (da) Fremgangsmaade til fremstilling af piperidindionderivater, der beskytter hjertemuskulaturen med en antiarythmisk aktivitet
EP0071935A3 (en) 1-phenyl-2-aminocarbonylindole compounds, process and intermediates for their preparation and medicines containing them
HUT53641A (en) Process for producing new, anellated 1h-indolo-2-carboxylic acid-n-(1,4-benzodiazepin-3-yl)-amides and pharmaceutical composition containing them
PT99563A (pt) Processo para a preparacao de aminas biologicamente activas
PT86160A (de) Verfahren zur herstellung von mono-, bi- und tricyclischen aminosaeuren zwischenprodukte dieses verfahrens sowie ein verfahrenzu deren herstellung
ATE56449T1 (de) Neue beta-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel (h).
ATE143960T1 (de) Substituierte arylamine und heteroarylamine, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzung
DE3867073D1 (de) Allylmercaptoacetyl-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
ATE7917T1 (de) Pyranoindolderivat und verfahren zu seiner herstellung.
SE7605146L (sv) Forfarande for framstellning av aminer
ES453121A1 (es) Un metodo de preparacion de nuevos derivados de piridil u- reas.
GB808050A (en) Acyl phenothiazine-10-carboxylic acid esters
ATE80877T1 (de) Verfahren zur herstellung von 6-piperidino-2,4diaminopyrimidin-3-oxid, und verbindungen.
ATE91077T1 (de) Verwendung von cinnamamid-derivaten zur entspannung der muskeln.
ATE12238T1 (de) Neue ketale von 3'''-dehydro-cardenolidtridigitoxosiden, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE53839T1 (de) 2,3-dihydro-3-phenyl-benzofuran-2-onacetamidderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE9091T1 (de) Substituierte phenoxyacetate cyclischer amine, verfahren zu ihrer herstellung, ihre anwendung als heilmittel und sie enthaltende pharmazeutische zusammensetzungen.
ATE2222T1 (de) Digoxin-derivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties